Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis

Programmed cell death protein-1 (PD-1) inhibitors have shown promising results for treating advanced hepatocellular carcinoma (HCC). However, the clinical utility of such inhibitors in HCC patients with vascular tumor thrombosis remains unclear. This study investigated PD-1 inhibitor efficacy in adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hong-Ming, Han, Meng-Zhi, Lin, Yih-Jyh, Chang, Ting-Tsung, Chen, Chiung-Yu, Cheng, Pin-Nan, Chuang, Chiao-Hsiung, Wu, I-Chin, Chen, Po-Jun, Kang, Jui-Wen, Chiu, Yen-Cheng, Chiu, Hung-Chih, Chien, Shih-Chieh, Kuo, Hsin-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195886/
https://www.ncbi.nlm.nih.gov/pubmed/33409737
http://dx.doi.org/10.1007/s00262-020-02845-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195886/
https://www.ncbi.nlm.nih.gov/pubmed/33409737
http://dx.doi.org/10.1007/s00262-020-02845-9

Ejemplares similares